The Sez6 family inhibits complement at the level of the C3 convertase.
Qiu, W. Q.; Luo, S.; Ma, S. A.; Saminathan, P.; Li, H.; Gunnersen, J. M.; Gelbard, H. A.; Hammond, J. W.
Show abstract
The Sez6 family consists of Sez6, Sez6L, and Sez6L2. Its members are expressed throughout the brain and have been shown to influence synapse numbers and dendritic morphology. They are also linked to various neurological and psychiatric disorders. All Sez6 family members contain 2-3 CUB domains and 5 complement control protein (CCP) domains, suggesting that they may be involved in complement regulation. We show that all Sez6 family members inhibit C3 deposition by the classical and alterative pathways with varying degrees of efficacy. For the classical pathway, Sez6 is a strong inhibitor, Sez6L2 is a moderate inhibitor, and Sez6L is a weak inhibitor. Using Sez6L2 as the representative family member, we show that it specifically deactivates C3 convertases by accelerating the decay or dissociation of the C3 convertase components. Sez6L2 also deactivates C3 convertases of the alternative pathway by serving as a cofactor for Factor I to facilitate the cleavage of C3b. However, Sez6L2 has no cofactor activity toward C4b. In summary, the Sez6 family are novel complement regulators that inhibit C3 convertases.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5 95%
- Heparan Sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE 93%
- Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes 92%
Similar papers in this journal
- Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s 94%
- Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies 94%
- Design of a Streptococcus pyogenes M protein immunogen to elicit M type cross-reactivity 94%
Similar papers in this journal
- Pro-inflammatory chemokines CCL5, CXCL12, and CX3CL1 bind to and activate platelet integrin αIIbβ3 in an allosteric manner. 92%
- Molecular dissection of neurodevelopmental disorder-causing mutations in CYFIP2 91%
- α-synuclein preformed fibrils bind to β-neurexins and impair β-neurexin-mediated presynaptic organization 90%
Similar papers in this journal
- SARS-CoV2 mutant-specific T cells and neutralizing antibodies after vaccination and up to 1 year after infection 92%
- Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. 92%
- Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice 91%
Similar papers in this journal
- Platelet Derived Growth Factor Receptor β (PDGFRβ) is a Host Receptor for the human malaria parasite adhesin TRAP 92%
- Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders. 92%
- Heterologously secreted MbxA from Moraxella bovis induces a membrane blebbing response of the human host cell 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.